Eastern Cooperative Oncology Group performance status (ECOG PS) is a key confounder in comparative effectiveness research, predicting treatment and survival, but is often incomplete in electronic ...
Incorporating ICIs into platinum-doublet regimens improved OS and ORR in ES-SCLC patients with ECOG PS 2 to 3, but not in those with ECOG PS 0 to 1. The study found manageable adverse reactions, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback